Q3 was a precarious but productive quarter in the IPO market with 63 deals priced. That compares to 83 in Q2 and 67 in Q1. We say precarious because the markets fluctuated quite a bit with the Russell 2000 down 7.4% during the quarter.

The Israel-based medical device company ReWalk develops and sells wearable exoskeletons that enable mobility-impaired patients to walk. The company went public and saw its shares more than doubled in their stock market debut.

RWLK is an “opportunity stock” and positioning itself as the leader to allow paralyzed people to walk. But what about the competition? Ekso Bionics, Landauer, Amedica Corp., and K2M target the same area with different therapies that are worth looking at...